Medical cannabis is expected to reach 56.7B market value by 2026. On this episode we hear from Oxford Cannabinoid Technologies co-founders Neil Mahapatra (Kingsley Capital Partners, Rothschild, Morgan Stanley) and Gavin Sathianathan (Alta Flora, Facebook, Bain) about their use of technological advances and a network innovation model to develop patient-saving pharmaceuticals from cannabis.
Music from: https://freesound.org/
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More